Portland, Oregon
Program Director(s):
Michele Babicky
Jon Gerry
Description:
The Providence HPB Fellowship position was created in 2008, although it has been integrated with a minimally invasive surgical (MIS) Fellowship in existence for more than 25 years. The Fellowship is intended for physicians who have completed a general surgery residency and have a particular interest in hepatobiliary and pancreatic surgery and research. The program attendings are fellowship trained in hepatobiliary and pancreatic surgery, surgical oncology, advanced laparoscopic surgery, and surgical ultrasound. The program's strengths include extensive experience in advanced open and minimally invasive surgical procedures. The practice includes both benign and malignant disease processes. Additional areas of focus include intraoperative ultrasound and surgical tumor ablation. The fellowship is two years in length. The first year is primarily clinical on the HPB service. The second year is a mixture of clinical, research, and administrative time. Clinical experiences may be arranged in colorectal, foregut, organ transplant, surgical endoscopy and/or interventional radiology, depending on the fellow’s interests. Fellows are expected to accumulate a clinical experience of 200-250 advanced HPB and GI surgeries. The fellow will interact with surgical residents, but has the first right of refusal on all HPB cases. Our program is very hands-on for the fellows, with a goal of producing graduates who are capable and comfortable performing major HPB cases independently. Research is a required component of the fellowship. Fellows are expected to initiate clinical research projects with the goal of producing at least 3 presentable/publishable projects. Fellows have access to a basic science immunology lab, a large clinical database, animate and inanimate labs, and NOTES labs. Fellows are involved in teaching residents, participating in surgical training courses, and participating in HPB Program administration. The Fellowship offers high volume of cases, academic opportunities and mentorship by leading surgeons in the fields of HPB surgery, MIS, and GI surgical oncology. The setting is Providence Portland Medical Center, a community based, academic health care center located in Portland, Oregon. The fellow will gain the necessary skills and experience required to function as an independent HPB surgeon and develop sufficient clinical, research and administrative skills to develop or build their own HPB program. **Please note, we do not accept J1 Visa's
Basic Program Information:
- Location: Portland, Oregon
- Primary Program Site: Providence Portland Medical Center
- Primary Hospital: Total bed size, # OR's, # Surgical ICU beds:
- Secondary Program Site: Good Samaritan Hospital, Legacy Health System
- Secondary Hospital: Total bed size, # OR's, # Surgical ICU beds:
- Clinic locations and schedule:
Providence Portland Medical Center
Monday and Wednesday
- University Affiliation:
- School of Medicine Affiliation:
- Year Program Established: 2008
- Number of Faculty:
- % of Program Clinical: 80
- % of Program Research: 20
Additional Program Information:
- Interaction with Residents: Do not share cases with residents
- Is there a General Surgery Residency at the Primary Institution? No
- Is there a General Surgery Residency at the Secondary Institution? No
- Is there a curriculum in place for fellowship? Yes
- Is there a skills lab at the institution with fellow access? Yes
- Are there teaching conferences available for the fellow? Yes
- Is there an evaluation tool for fellow by faculty in place? Yes
- Is there an evaluation tool for faculty by fellow in place? Yes
- Papers Accepted For Publication where PD was an author: 20
- Publications that Involved Input from the Fellow: 12
Malpractice Insurance Information:
- The fellow(s) only works as a fellow, i.e. does not/will not have attending privileges and the program provides the following:Claims-based malpractice coverage including a tail for the statute of limitations
Contact Information For Questions:
Alyx Wheatcroft
Phone: 503-215-9688
Fax: 503-215-3201
Email: [email protected]
Web: http://www.providence.org/oregon/cancer
Facilities
Dry Lab
Wet lab
Library
Administrative Support
Basic Science Research
Clinical Research
Simulation Lab
Citizenship and Visa Requirements:
US Citizens US Permanent Residents (Green Card)Medical School Requirements:
We accept graduates of U.S. or Canadian Medical Schools and Foreign Medical Schools We accept graduates of Foreign Medical Schools only if ECFMG CertifiedExaminations and Certifications:
Applicants must have passed the USMLE/COMLEX Step 1, 2, & 3 exams Applicants must have passed the USMLE/COMLEX Step 1 & 2 exams or the Medical Council of Canada Evaluation Exam (MCCEE) Applicants must have had at least 2 years of prior training in an ACGME accredited residency or fellowship (or Canadian equivalent) Applicants who are ABS or Canadian Board Eligible or Certified Applicants must have had at least 2 years of prior training in an AOA (American Osteopathic Association) accredited residency or fellowship Applicants must be AOBS (American Osteopathic Board of Surgery) eligible or certifiedLicensure Requirements and Information:
| Accreditation Status | Accreditation Period | Length of Accreditation | Accredited for HPB | 2022-2024 | 2 |
|---|
Fellowship Opportunity # 1
- Number of Positions Available: 1
- Type of Fellowship: HPB
- Duration: 2 year
- Start Day: August 1
- End Day: July 31
- Is this a salaried position? Yes
- It is a requirement that the salary must be commensurate to a PGY 6 or greater in the same city. Does your program meet this requirement? Yes
- Is the salary guaranteed for the year? Yes
- Is there funding available beyond salary for meeting attendance, research, etc? Yes
- Is the salary dependent on call? No
- Is the Fellow on call?
Yes
What are the on call requirements? - What are the estimated fellow weekly work hours?
- It is a requirement that Health Insurance be provided. Do you provide health insurance to your fellows? Yes
- Teaching Responsibilities: Yes
- Courses/Academic Presentations: Yes
- Does reimbursement for the above make up part of the salary? No
- Does the fellowship contract include a non-compete clause? No
Clinical Outpatient Experience
HPB Fellows will have clinical outpatient experience in the HCC clinic and Liver and Pancreas surgery clinic.
Research/Scholarship Resources
The Fellows are integral participants in our productive research program. They participate with post-doctoral researchers and research fellows in weekly research meetings and in the administration of a variety of clinical and lab based research efforts. Support available includes faculty mentors, a clinical research nurse and their co-researchers. They have unlimited access to state of the art basic science labs and our animal/cadaver procedural investigation lab.
They are fully supported for two meetings/year - and for any additional meetings where they have a presentation accepted.
Program Director(s) Detailed Information
Dr. Michele Babicky
- At Institution Since: 2018
- Program Director Since : 2022
- Board Certification: Board Certified
Society Memberships
ACS
AHPBA
Other
SSO
Areas of Expertise
HPB and MIS SurgeryTeaching Qualifications
Academic Awards
Brennan Visiting Resident, Memorial Sloan-Kettering Cancer Center, October 2015
Recipient, AHPBA Research Fellowship 2011-2012
Recipient, NIH Loan Repayment Program
American College of Surgeons Excellence in Research Award
Best Oral Presentation, UCSD Surgery Research Day
MedSTARS Medical Student Research AwardMartin, Shaw, and Walker Scholarships (MS III, IV)
Dean’s Recognition, Keck School of Medicine
American Institute of Chemists Award for Outstanding Achievement in Chemistry
NINDS, NIH Research Training Award
American Chemical Society Organic Chemistry Award
CRC Press Award for Outstanding Achievement in Freshman Chemistry
Phi Beta Kappa
Gamma Sigma Epsilon, Chemistry Honor Society, Chapter President
Professional Activities
Assistant Administrative Chief Resident (2014-15)
Administrative Board, Organization of Resident Representatives, American Association of Medical Colleges (2014-Present)
Curriculum Coordinator, UCSD General Surgery Basic Science Conference
Peri-operative Services Committee (2009-2011)
Resident Physician Council, Co-chair (2010-11), Treasurer (2011-12)
American Medical Women’s Association, Chapter Secretary (2008)
Physicians for Social Responsibility, Chapter Vice-President (2008)
Tour Guide and Interviews, Keck School of Medicine Admissions
Student Surgical Interest Group
Teaching Assistant, Head and Neck Anatomy, June-August 2006
Teaching Assistant, Organic Chemistry Laboratory, January-May 2002
Summary of Qualifications
Hospital Affiliations
Medical Director, Hepatopancreatobiliary (HPB) Surgery
HPB Fellowship Program Director
Providence Portland Medical Center
4805 NE Glisan St., Suite 6N60
Portland, OR 97213
Legacy Good Samaritan Medical Center
2222 NW Lovejoy, Suite 601
Portland, OR 97210
Education
Fellow, Complex General Surgical Oncology
Memorial Sloan-Kettering Cancer Center, New York, NY
08/2016-07/2018
Categorical Resident, General Surgery
University of California, San Diego Medical Center, San Diego, CA
07/2008-06/2016 (Research PGY3-5, 2010-13)
M.D., Keck School of Medicine, University of Southern California, Los Angeles, CA
08/2004-05/2008
Publications
Washington K, Augustin T, Babicky M, Gray D, Asfaw S, Cendales L Pawlik T, Warner S, Clark C, Floyd TL. AHPBA School of Equitable Research: A Lesson on Our Commitment to Diversity, Equity, and Inclusion, In Submission HPB 11/2021
Tang E, Hansen PD, Newell PH, Babicky ML, Gerry J, Wu Y, Dubay CJ, Bernard BM, Rajamanickam V, Zhaoyu S, Young KH, Crittenden MR, Gough MJ. Comparative Subtyping of an Upfront Resected Cohort of Pancreatic Adenocarcinoma using immunohistochemical and RNAseq-based approaches to determine treatment unresponsive subgroups, In submission HPB 10/2021
Babicky ML, Harper MM, Chakedis J, Cazes A, Mose ES, Jaquish DV, French RP, Childers B, Alakus H, Schmid MC, Foubert P, Miyamoto J, Holman PJ, Walterscheid ZJ, Tang CM, Varki N, Sicklick JK, Messer K, Varner JA, Waltz SE, Lowy AM. MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages. 2019 Jul; 38 (28):5599-5611.
Chakedis J, French R, Babicky M, Jaquish D, Mose E, Cheng P, Holman P, Howard, H, Miyamoto J, Porras P, Walterscheid Z, Schultz-Fadermrecht C, Esdar C, Schadt O, Eickhoff J, Lowy AM. Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics. Oncotarget. 2016 Jul 19; 7(29): 45959-45975.
Chakedis J, French R, Babicky M, Jaquish D, Howard H, Mose E, Lam R, Holman P, Miyamoto J, Walterscheid Z, Lowy AM. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells. 2016 Jun 23; 35(25):3249-59.
Alakus H, Babicky ML, Ghosh P, Yost S, Jepsen K, Dai Y, Arias A, Samuels ML, Mose ES, Schwab RB, Peterson MR, Lowy AM, Frazer KA, Harismendy O. Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin. Genome Med. 2014 Jul 26; 6(7):53
Sicklick, JK, Leonard SY, Babicky ML, Tang CM, Mose ES, French RP, Jaquish, DV, Hoh CK, Peterson M, Schwab R, Lowy AM. Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumors. J Trans Med 2014 Feb 10; 12:41
Babicky ML, Kang CM, Lowy AM. The RON receptor tyrosine kinase in pancreatic cancer pathogenesis and its potential implications for future targeted therapies. Pancreas 2014 Mar 43(2):183-9.
Yu, PT, Babicky, M, Jaquish, D, French, R, Marayuma, K, Mose, E, Niessen, S, Hoover, H, Shields, D, Cheresh, D, Cravatt, BF, Lowy, AM. The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome. Int J Cancer. 2012 Oct 15;131(8):1744-54.
Barmparas, G, Inaba, K, Teixeira PG, Dubose JJ, Criscuoli M, Talving P, Plurad D, Green D, Demetriades D. Traumatic Amputations at a Level 1 Trauma Center. Am Surg. 2010 Nov;76(11):1214-22.
Criscuoli, ML, Nguyen, M, and Eliceiri, BP. Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. Blood, 2005 Feb 15;105(4):1508-14.
Poster Presentations
Babicky, ML, Harper, MM, Mose, E, Jaquish, D, Marayuma, K, French, R, Lowy, AM. RON Overexpression Drives Macrophage Differentiation Toward an Alternatively Activated (M2) Phenotype in a Mouse Model of Pancreatic Carcinogenesis. American Association of Cancer Research Special Conference on Pancreas Cancer, June 20, 2012
Babicky, ML, Harper, MM, Mose, E, Jaquish, D, Marayuma, K, French, R, Lowy, AM. RON Overexpression Accelerates Tumorigenesis and Induces Metastasis in a KRAS Mutant Mouse Model of Pancreatic Cancer. Poster of Distinction, Pancreas Club, May 19, 2012
Oral Presentations
Babicky, M. Institut de Recherche contre les Cancers de l’Appareil Digestif (IRCAD) Management of Acute Pancreatitis April 2021 Virtual Meeting: France
Babicky, ML. Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Devil’s in the Details: Pancreas- Management and Mitigation of Post-operative Complications September 2021: Las Vegas, NV
Babicky, ML. AHPBA Bernard Langer Fellows Symposium, First Five Years in Practice, August 2021: Miami, FL
Gerry JM, Alonso E, Babicky ML, Hansen PD, Newell PH. AHPBA Hepatectomy for hepatocellular carcinoma in patients with elevated pre-operative bilirubin: An ACS-NSQIP HPB collaborative analysis. August 2020: Miami, FL
Babicky, ML, Harper, M, Mose, E, Jaquish, D, Marayuma, K, French, K, Lowy, AM. Targeting the RON Tyrosine Kinase Receptor in Pancreatic Cancer. Next Generation Pathology Conference, February 12, 2013, Invited Speaker
Babicky, ML and Lowy, AM. Targeting the RON Tyrosine Kinase Receptor in Pancreatic Cancer. Americas Hepato-Pancreatico-Biliary Association, Research Fellowship Award Presentation, March 9, 2012
Babicky, ML, Harper, M, Mose, E, Jaquish, D, Marayuma, K, French, K, Lowy, AM. RON OverexpressionAccelerates Tumorigenesis and Induces Metastasis in a KRAS Mutant Mouse Model of Pancreatic Cancer. American College of Surgeons, Surgical Forum, October 24, 2011
Babicky, ML, Jaquish, D, Mose, E, Yu, PT, French, R, Lowy, AM. Combining RON and EGFR Kinase Directed Therapy Markedly Inhibits Orthotopic Pancreatic Cancer Growth, Society of University Surgeons/Association of Academic Surgeons American Surgical Congress, February 2, 2011
Yu, PT, Babicky, ML, Jaquish, D, French, R, Lowy, AM. The RON Receptor Drives Pancreatic Cancer Cell Migration Through Phosphorylation Dependent Breakdown of the Hemidesmosome. Society of University Surgeons/Association of Academic Surgeons American Surgical Congress, February 1, 2011
Babicky, ML, Chang, D, Lowy, AM. Lymph Node Metastasis is associated with Decreased Survival in Patients with Low Grade Mucinous Adenocarcinoma of the Appendix with Peritoneal Dissemination: An analysis of the National Cancer Institute (NCI) Survival Epidemiology and End Results (SEER) Database, Pacific Coast Surgical Association, February 19, 2011
Criscuoli, M, Inaba K, Barmparas G, Teixeira, P, Plurad, D, Green, D, DuBose, J, Demetriades, D. Epidemiology of Traumatic Limb Amputations. USC Surgery Grand Rounds. April 18, 2008
Criscuoli, M, Correa, A, Singh, G, Genyk, Y, Jabbour, N, Sher, L, Selby, R, Mateo, R. Diagnosis and Treatment of Hepatosplenic Post-Transplant Lymphoproliferative Disorder in a Renal Transplant Recipient. Western Medical Student Research Forum. Monterey, CA February 4, 2006
Jon Gerry
- At Institution Since: 0
- Program Director Since : 0
- Board Certification:
Society Memberships
Areas of Expertise
Teaching Qualifications
Summary of Qualifications
Division of Time
Percentage of Time Spent in Clinical Activity:
80%
Percentage of Time Spent in Research
Activity:20%
Case Load as Reported By Fellow(s)
2 Fellow(s) performed 148 cases with 403 procedures during the 2022-2023 Fellowship Year.
2 Fellow(s) performed 266 cases with 530 procedures during the 2021-2022 Fellowship Year.
List of Contributing Faculty
| Michele Babicky MD | 34% |
| Area of Expertise HPB |
|
| Role in Training Clinical Surgeon, Research Advisor |
|
| Jon Gerry MD, FAS | 33% |
| Area of Expertise |
|
| Role in Training Clinical Surgeon |
|
| John Creasy MD | 33% |
| Area of Expertise |
|
| Role in Training Clinical Surgeon |
|
Accreditation History
| Director | Program | Length | Start | End | |
|---|---|---|---|---|---|
| Paul D Hansen | HPB | 2 | 2022 | 2024 |